WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Discover www.zeiss.de/functionality
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Huang, L. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, L.
Right arrow Articles by Huang, L. Y.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 15, 4602-4611, Copyright © 1995 by Society for Neuroscience

ARTICLE

The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin

L Chen, Y Gu and LY Huang
Marine Biomedical Institute, University of Texas Medical Branch, Galveston 77555-1069, USA.

Dynorphin is one of the endogenous opioids that modulates the excitability of nociceptive (pain-sensing) neurons. We have shown recently that dynorphin blocks NMDA-activated currents directly without the participation of kappa-opioid receptors. In order to understand the mechanism underlying this novel action of dynorphin, we examined, in detail, the interactions between dynorphin and NMDA receptors in isolated trigeminal neurons. Dynorphin reversibly blocks NMDA-activated current (INMDA). The onset and recovery of the block were determined with concentration jump experiments. The association rate (k+) of dynorphin(1-17) is 4.9 x 10(6) sec-1 M-1 and the dissociation rate (k-) is 7.5 sec-1. The apparent dissociation constant (KD) of dynorphin, calculated from these rate constants, is 1.6 microM. Dynorphin does not change the EC50 of NMDA, nor the potentiating action of glycine. The binding site for dynorphin is distinct from that of Zn2+ or H+. Upon treatment with the disulfide reducing agent dithiothreitol (DTT), NMDA receptors become less susceptible to dynorphin block. The affinity of dynorphin for the modified NMDA receptors is reduced by 2.7-fold. In analyses of single NMDA channels in cell-free patches, we found that dynorphin shortens the mean open time, decreases the probability of opening of NMDA channels, but has no effect on the single channel conductance. These results suggest that dynorphin interacts with a site conformationally linked with the redox site(s) on the NMDA receptor, thus altering the gating properties of the channel.


This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
M. Raiteri
Functional pharmacology in human brain.
Pharmacol. Rev., June 1, 2006; 58(2): 162 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. M. Laughlin, A. A. Larson, and G. L. Wilcox
Mechanisms of Induction of Persistent Nociception by Dynorphin
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 6 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
J. Lai, M. H. Ossipov, T. W. Vanderah, T. P. Malan Jr., and F. Porreca
Neuropathic Pain: The Paradox of Dynorphin
Mol. Interv., August 1, 2001; 1(3): 160 - 167.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
Q. Tang, R. M. Lynch, F. Porreca, and J. Lai
Dynorphin A Elicits an Increase in Intracellular Calcium in Cultured Neurons Via a Non-Opioid, Non-NMDA Mechanism
J Neurophysiol, May 1, 2000; 83(5): 2610 - 2615.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. I. Sobolevsky, M. V. Yelshansky, and B. I. Khodorov
Eosine-Induced Blockade of N-Methyl-D-aspartate Channels in Acutely Isolated Rat Hippocampal Neurons
Mol. Pharmacol., February 1, 2000; 57(2): 334 - 341.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
Q. Tang, R. Gandhoke, A. Burritt, V. J. Hruby, F. Porreca, and J. Lai
High-Affinity Interaction of (des-Tyrosyl)Dynorphin A(2-17) with NMDA Receptors
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 760 - 765.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
A. Galli, L. D. Jayanthi, I. S. Ramsey, J. W. Miller, R. T. Fremeau Jr, and L. J. DeFelice
L-Proline and L-Pipecolate Induce Enkephalin-Sensitive Currents in Human Embryonic Kidney 293 Cells Transfected with the High-Affinity Mammalian Brain L-Proline Transporter
J. Neurosci., August 1, 1999; 19(15): 6290 - 6297.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis
The Glutamate Receptor Ion Channels
Pharmacol. Rev., March 1, 1999; 51(1): 7 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
S. P. Schneider, W. A. Eckert III, and A. R. Light
Opioid-Activated Postsynaptic, Inward Rectifying Potassium Currents in Whole Cell Recordings in Substantia Gelatinosa Neurons
J Neurophysiol, December 1, 1998; 80(6): 2954 - 2962.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. Chen and L.-Y. M. Huang
Dynorphin Block of N-Methyl-D-Aspartate Channels Increases with the Peptide Length
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 826 - 831.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Sun, S. G. Rane, P. G. Gunasekar, J. L. Borowitz, and G. E. Isom
Modulation of the NMDA Receptor by Cyanide: Enhancement of Receptor-Mediated Responses
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1341 - 1348.
[Abstract] [Full Text]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-